About HiberGene
HiberGene is a company based in Dublin (Ireland) founded in 2009 by Peter Kidney. It operates as a B2B. HiberGene has raised $14.32 million across 9 funding rounds from investors including Cantor, Enterprise Ireland and European Union. HiberGene offers products and services including LAMP Technology, HG MENINGOCOCCUS, HG GBS, and HG SWIFT. HiberGene operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Dublin, Ireland
- Founders Peter Kidney
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hibergene Diagnostics Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.32 M (USD)
in 9 rounds
-
Latest Funding Round
-
Investors
Cantor
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HiberGene
HiberGene offers a comprehensive portfolio of products and services, including LAMP Technology, HG MENINGOCOCCUS, HG GBS, and HG SWIFT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid amplification system for detecting infectious diseases.
Test for meningococcus meningitis detection.
Diagnostic for Group B Streptococcus.
Platform for swift molecular diagnostics.
Funding Insights of HiberGene
HiberGene has successfully raised a total of $14.32M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Last Round
-
First Round
First Round
(02 Feb 2015)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Grant - HiberGene | Valuation |
investors |
|
| Apr, 2020 | Amount | Series B - HiberGene | Valuation |
investors |
|
| Feb, 2020 | Amount | Grant - HiberGene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HiberGene
HiberGene has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Cantor, Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Shackleton Ventures is focused on secondary venture and development capital investments.
|
Founded Year | Domain | Location | |
|
VC firm investing in the UK and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HiberGene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HiberGene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hibergene Comparisons
Competitors of HiberGene
HiberGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hibergene
Frequently Asked Questions about HiberGene
When was HiberGene founded?
HiberGene was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Where is HiberGene located?
HiberGene is headquartered in Dublin, Ireland.
Is HiberGene a funded company?
HiberGene is a funded company, having raised a total of $14.32M across 9 funding rounds to date. The company's 1st funding round was a Grant of $698K, raised on Feb 02, 2015.
What does HiberGene do?
HiberGene Diagnostics Limited is a private Irish company that specializes in molecular technology for the in-vitro diagnostics market. It focuses on creating rapid amplification platforms to detect infectious diseases, particularly meningitis, through tests like HG MENINGOCOCCUS. Founded in 2009 by experts from the Royal Victoria Hospital in Belfast, the company collaborates with institutions such as Queens University and partners like Eiken Chemical. It operates globally, aiming to improve diagnostic precision for healthcare providers.
Who are the top competitors of HiberGene?
HiberGene's top competitors include Visby Medical, Inflammatix and MeMed.
What products or services does HiberGene offer?
HiberGene offers LAMP Technology, HG MENINGOCOCCUS, HG GBS, and HG SWIFT.
Who are HiberGene's investors?
HiberGene has 7 investors. Key investors include Cantor, Enterprise Ireland, European Union, Medcaptain, and EIC Fund.